Oncology Research
DOI: 10.3727/096504022X16420719767471
images

Retraction

Retraction Notice to “Long Noncoding RNA LINC01133 Functions as an miR-422a Sponge to Aggravate the Tumorigenesis of Human Osteosarcoma” [Oncology Research 26(3) (2018) 335–343]

HAI-FENG ZENG*, HAI-YAN QIU† and FA-BO FENG‡,*

*Department of Plastic Surgery, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou, P.R. China
†Department of Endocrinology, Hangzhou First People’s Hospital, Nanjing Medical University, Nanjing, P.R. China
‡Department of Orthopedics, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou, P.R. China
*Address correspondence to Fa-Bo Feng, Department of Orthopedics, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, No. 158 Shangtang Road, Hangzhou, Zhejiang 310014, P.R. China. Tel: +86-0571-85239988; E-mail: fengfabo_star@126.com

Retraction statement: Several weeks ago, we made a self-inspection of our published papers. The corresponding author found the images in Figures 2 and 4 contained some errors. After repeated part of the experiment, we now feel that the experimental results may be not solid enough to support the conclusions. We have therefore made the decision to withdraw the article with the agreement of all listed authors. All the listed authors apologize to the readership for any inconvenience caused.

images
Copyright © 2024 The Author. Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Table of Contents

Retraction notice to “Long Noncoding RNA LINC01133 Functions as an miR-422a Sponge to Aggravate the Tumorigenesis of Human Osteosarcoma” [Oncology Research 26(3) (2018) 335–343]

Guide

Retraction notice to “Long Noncoding RNA LINC01133 Functions as an miR-422a Sponge to Aggravate the Tumorigenesis of Human Osteosarcoma” [Oncology Research 26(3) (2018) 335–343]